Rifampin Capsules USP — Class II drug recall D-0165-2023
Terminated recall by Amerisource Health Services LLC, reported 2023-01-25, distributed nationwide. Failed Impurities/Degradations Specifications
| Recall number | D-0165-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2022-12-20 |
| Classified | 2023-01-18 |
| Reported by FDA | 2023-01-25 |
| Terminated | 2024-09-06 |
| Distributed | Nationwide (US) |
| Quantity | 3,091 cartons |
| Reason classes | specification failure |
| NDC | 60687-0575, 60687-0575-11, 60687-0575-21, 60687-0586, 60687-0586-01, 60687-0586-11 |
| Lot numbers | 1007805 |
| Expiration dates | 2023-12-31 |
Product
Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11)
Reason for recall
Failed Impurities/Degradations Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0165-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.